Elisa Bellini

#regulatoryaffairs #medicaldevices #AI #ML #SaMD #QMS #IVD

[Elisa Bellini @drElisaBellini]

@PADI 🧘🏻‍♀️ 🤩 ❤️

[Elisa Bellini @drElisaBellini]

#SMR2022 Come check out our Poster at The 19th International Congress of the Society for Melanoma Research. @societymelanoma - via #Whova event app

[Elisa Bellini @drElisaBellini]

@Cancers_MDPI #personalizedmedicine #liquidbiopsy #personalizedcancercare #melanoma #ddPCR

[Elisa Bellini @drElisaBellini]

The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma https://t.co/ERZaZEdonN #mdpicancers via @Cancers_MDPI

[BLOODPAC @blood_pac]

A tissue based sample of a cancerous tumor may not fully represent the heterogeneity of the site, unfortunately this can cause therapeutic failures. Liquid biopsy may provide a more complete molecular profile that will lead to more successful treatment.

Information is power 🔬👩🏾‍🔬

[Elisa Bellini @drElisaBellini]

A Comparative Study of Real-Time RT-PCR–Based #SARSCoV2 Detection Methods and Its Application to Human-Derived and Surface Swabbed Material - The Journal of Molecular Diagnostics https://t.co/e5XNbh4Oyy

[Elisa Bellini @drElisaBellini]

I voted for Oncobit AG to win the TOP 100 Swiss Startup Public Vote 2021! Vote too: https://t.co/EhJnin6JFo

[Elisa Bellini @drElisaBellini]

A comparative study of real-time RT-PCR-based #SARSCoV2 detection methods https://t.co/e5XNbh4Oyy